Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
8.17
-5.08
-62.18%
Share Warrants & Outstandings
Total Reserve
68.71
7.12
61.59
865.03%
Shareholder's Funds
71.80
15.29
56.51
369.59%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
1.17
-1.17
-100.00%
Secured Loans
0.00
0.23
-0.23
-100.00%
Unsecured Loans
0.00
0.94
-0.94
-100.00%
Deferred Tax Assets / Liabilities
0.11
0.19
-0.08
-42.11%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.11
1.36
-1.25
-91.91%
Current Liabilities
Trade Payables
38.70
7.59
31.11
409.88%
Other Current Liabilities
0.94
2.70
-1.76
-65.19%
Short Term Borrowings
9.91
12.94
-3.03
-23.42%
Short Term Provisions
0.02
0.00
0.02
0.00%
Total Current Liabilities
49.58
23.23
26.35
113.43%
Total Liabilities
121.49
39.87
81.62
204.72%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.85
7.09
9.76
137.66%
Less: Accumulated Depreciation
6.37
1.00
5.37
537.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.48
6.09
4.39
72.09%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.44
0.00
3.44
0.00%
Long Term Loans & Advances
0.75
0.08
0.67
837.50%
Other Non Current Assets
3.46
0.16
3.30
2,062.50%
Total Non-Current Assets
18.13
6.33
11.80
186.41%
Current Assets Loans & Advances
Current Investments
0.36
0.00
0.36
0.00%
Inventories
38.01
20.61
17.40
84.43%
Sundry Debtors
56.54
11.66
44.88
384.91%
Cash and Bank
0.16
0.05
0.11
220.00%
Other Current Assets
0.17
0.12
0.05
41.67%
Short Term Loans and Advances
8.13
1.10
7.03
639.09%
Total Current Assets
103.36
33.55
69.81
208.08%
Net Current Assets (Including Current Investments)
53.78
10.32
43.46
421.12%
Total Current Assets Excluding Current Investments
103.00
33.55
69.45
207.00%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
121.49
39.87
81.62
204.72%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
9.91
14.10
-4.19
-29.72%
Book Value per share (adjusted)
232.39
18.71
213.68
1,142.06%
Annual - Borrowings
Borrowings 9.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Annual - Investments
Investments 3.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Annual - Current Assets
Current Assets 103.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024






